ILMN Q4 Earnings Preview: NovaSeq X Momentum Likely to Aid Performance

Key Takeaways Illumina reports Q4 results on Feb. 5, with EPS estimated at $1.26, up 46.5% YoY.Illumina's NovaSeq X and MiSeq i100 adoption likely boosted high and low-throughput sequencing revenues.New multiomic products and strategic partnerships may have further supported Illumina's Q4 revenues.Illumina, Inc. (ILMN) is set to release fourth-quarter 2025 results on Feb. 5, after the closing bell.The company posted adjusted earnings per share (EPS) of $1.34 in the last reported quarter, which surpassed the ...